Cacecon 667mg Tablet

About

Cacecon 667mg Tablet contains Calcium Acetate, a highly effective phosphate binder primarily used in the management of hyperphosphatemia. This condition, characterized by abnormally high phosphate levels in the blood, is commonly seen in patients with end-stage renal disease (ESRD) who are undergoing dialysis. Calcium acetate works by binding to dietary phosphate in the gastrointestinal tract, forming insoluble calcium phosphate complexes that are then excreted in the feces. This action prevents the absorption of phosphate into the bloodstream, thereby helping to lower serum phosphate levels. Effective control of hyperphosphatemia is crucial to prevent serious complications such as renal osteodystrophy, soft tissue calcification, and cardiovascular disease, significantly improving the quality of life and prognosis for patients with chronic kidney disease.

Uses

• Treatment of hyperphosphatemia in ESRD
• Management of chronic kidney disease
• Phosphate control in dialysis patients
• Prevention of renal osteodystrophy

Directions For Use

Take this tablet with meals to maximize its phosphate-binding effect, as directed by your physician. Do not chew or crush the tablet.

Benefits

• Effectively lowers serum phosphate levels
• Prevents soft tissue calcification
• Reduces risk of renal osteodystrophy
• Improves bone health in CKD patients
• Supports cardiovascular health in CKD
• Helps manage mineral and bone disorder

Side Effects

• Nausea
• Vomiting
• Constipation
• Diarrhea
• Abdominal pain
• Hypercalcemia (if absorbed excessively)
• Flatulence
• Headache
• Muscle weakness
• Dry mouth
• Loss of appetite
• Increased thirst

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol intake should be avoided as it can exacerbate gastrointestinal issues.
• Pregnancy - Use only if clearly needed and potential benefits outweigh risks; monitor maternal calcium levels closely.
• Breastfeeding - Use with caution; monitor the infant for signs of hypercalcemia. Consult your doctor.
• Liver - Generally safe for use in patients with liver conditions as it is not significantly metabolized by the liver.
• Kidney - Primarily used for kidney disease, but monitor serum calcium and phosphate levels closely to avoid hypercalcemia.
• Lung - No direct significant interaction or specific precautions related to lung conditions are typically noted.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.